Gynecological and Obstetric Diseases Biomarker Detection Service

Gynecological and obstetric diseases are a type of female common and frequently-occurring diseases, and its early diagnosis is of great significance for its clinical treatment. The research of biomarkers has an important position in the diagnosis and treatment of these diseases. As an expert in the field of biomarkers, Creative BioMart Biomarker has a first-class technology platform for single biomarker testing, which includes a variety of gynecological and obstetric diseases related biomarkers. Our experienced technical team can provide customers with high-quality inspection services to ensure the accuracy and repeatability of each detection.

Introduction

Gynecological diseases refer to a series of diseases related to the physiological and pathological changes of female reproductive system during non-pregnancy, including uterine diseases, fallopian tube diseases, ovarian diseases, vaginal diseases, etc. Gynecological diseases are a common and frequent type of diseases among females, which have many effects on normal life and physiological health, and even lead to the occurrence of tumors, endangering the lives of women. Obstetric diseases are diseases related to pregnancy and childbirth. Such diseases are closely related to premature delivery, disability, death, and the safety of pregnant women. Traditional diagnostic measures for obstetric diseases and gynecological diseases may rely more on pathological diagnosis, which usually depends largely on the experience and subjective judgment of pathologist, which may lead to misdiagnosis. The development of molecular biology has greatly promoted the development of biomarkers and brought tremendous changes to medical diagnosis. The emergence of biomarkers has influenced the diagnosis of these two types of diseases. It can support the diagnosis results of histopathology and help confirm the diagnosis results. The detection of biomarkers may be helpful in predicting the possibility of menopause, preeclampsia and preterm birth, as well as the diagnosis of endometriosis with a non-invasive test. The emergence of biomarkers has brought broad development prospects for noninvasive prenatal diagnosis. Testing of blood samples from pregnant women can analyze fetal developmental genes and sensory perception genes and identify high-risk pregnancy. In addition, the study of biomarkers is also conducive to the treatment of gynecological diseases and obstetric diseases. For example, research on the treatment of premenstrual dysphoric disorder. At present, the research of biomarkers in the field of obstetrics and gynecology is limited, and there is a broad space for development.

Gynecological and Obstetric Diseases Biomarker Detection ServiceFigure 1. Schematic of analyzing a fetal disease via the maternal plasma (Wagner, et al. 2019)

Our Advantages

  • Guarantee high accuracy and sensitivity for single biomarker detection
  • Ensure high repeatability of single biomarker detection
  • Short turn-around time of detection service
  • Competitive price in the market of detection services
  • Provide multiple detection methods
  • Accept a wide range of sample types

Our Single Biomarker Detection Services Related to Gynecological and Obstetric Diseases (including but not limited to the following):

  • Preeclampsia Biomarker Detection Service
  • Endometriosis Biomarker Detection Service
  • Menopause Biomarker Detection Service

Workflow of Single Biomarker Detection at Creative BioMart Biomarker

Creative BioMart Biomarker strictly controls each specific experimental step in the single biomarker detection procedure to ensure accurately quantify the level of each biomarker.

Gynecological and Obstetric Diseases Biomarker Detection Service

At Creative BioMart Biomarker, we offer gynecological and obstetric diseases biomarker detection services that include several technical platforms, you can communicate with our experts according to your research needs, and we will determine the final detection technological scheme based on the communication results. Please feel free to contact us, Creative BioMart Biomarker is here to offer you professional and thoughtful service.

References:

  1. Wagner, R.; et al. Prenatal maternal biomarkers for the early diagnosis of congenital malformations: A review. Pediatric Research. 2019, 86(5): 560-566.
  2. Jain, K.K. Biomarkers in Gynecology and Obstetrics. The Handbook of Biomarkers. 2017. pp. 689-700. Berlin: Springer.

Menu

Contact Us

Subscribe

Enter your email here to subscribe